Oncology Institute Inc
TOI3.805USD
+0.075+2.01%
交易中 （美东）报价延迟15分钟
338.37M总市值
亏损市盈率 TTM
关于 Oncology Institute Inc 公司
肿瘤研究所是一家以价值为基础的肿瘤学公司。该公司管理社区肿瘤学诊所，为美国 15 个市场和 5 个州的 83 个诊所的患者提供服务。该公司的部门包括患者服务、药房和临床试验及其他。其管理的诊所提供一系列医学肿瘤学服务，包括医生服务、内部输液和药房、放射、门诊血液制品输血等计划以及全天候患者支持。该公司通过 TOI Clinical Research, LLC (TCR) 为癌症患者提供和管理临床试验服务和研究。它还为独立肿瘤诊所拥有的 14 个诊所提供管理服务。该公司及其附属提供商与服务于各种患者的付款人建立了合同关系，包括医疗保险优势计划 (MA)、医疗补助计划和商业患者。
公司简介
公司代码TOI
公司名称Oncology Institute Inc
上市日期Mar 13, 2020
CEODr. Daniel Virnich, M.D.
员工数量825
证券类型Ordinary Share
年结日Mar 13
公司地址18000 Studebaker Rd
城市CERRITOS
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编90703
电话15627353226
网址https://theoncologyinstitute.com/
公司代码TOI
上市日期Mar 13, 2020
CEODr. Daniel Virnich, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.18M
-1.69%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
712.03K
+51.10%
Mr. Richard A. Barasch
Mr. Richard A. Barasch
Independent Chairman of the Board
Independent Chairman of the Board
496.69K
+47.30%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.17K
-0.68%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
198.04K
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
193.04K
-0.92%
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Director
Independent Director
183.35K
--
Mr. Gabriel Ling
Mr. Gabriel Ling
Independent Director
Independent Director
109.06K
--
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
98.04K
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.18M
-1.69%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
712.03K
+51.10%
Mr. Richard A. Barasch
Mr. Richard A. Barasch
Independent Chairman of the Board
Independent Chairman of the Board
496.69K
+47.30%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.17K
-0.68%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
198.04K
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
193.04K
-0.92%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
业务USD
名称
营收
占比
Dispensary revenue
49.29M
47.21%
FFS revenue
35.57M
34.07%
Capitated revenue
17.50M
16.76%
Clinical research trials and other revenue
2.04M
1.96%
暂无数据
业务
地区
业务USD
名称
营收
占比
Dispensary revenue
49.29M
47.21%
FFS revenue
35.57M
34.07%
Capitated revenue
17.50M
16.76%
Clinical research trials and other revenue
2.04M
1.96%
股东统计
更新时间: 6月26日 周四
更新时间: 6月26日 周四
持股股东
股东类型
持股股东
持股股东
占比
M33 Growth LLC
15.41%
OncologyCare Partners LLC
4.61%
Deerfield Management Company, L.P.
3.77%
TIFF Advisory Services, Inc.
3.34%
Balyasny Asset Management LP
2.41%
Other
70.48%
持股股东
持股股东
占比
M33 Growth LLC
15.41%
OncologyCare Partners LLC
4.61%
Deerfield Management Company, L.P.
3.77%
TIFF Advisory Services, Inc.
3.34%
Balyasny Asset Management LP
2.41%
Other
70.48%
股东类型
持股股东
占比
Venture Capital
15.47%
Investment Advisor
9.15%
Hedge Fund
7.19%
Individual Investor
4.72%
Corporation
4.61%
Insurance Company
1.39%
Investment Advisor/Hedge Fund
1.09%
Private Equity
0.28%
Research Firm
0.13%
Other
55.96%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
115
39.21M
43.94%
-20.76M
2025Q1
137
46.36M
52.04%
-13.47M
2024Q4
138
45.05M
59.62%
-19.81M
2024Q3
139
50.89M
67.39%
-11.59M
2024Q2
143
57.80M
76.77%
-3.05M
2024Q1
146
56.10M
75.87%
-3.90M
2023Q4
143
57.48M
77.79%
-4.30M
2023Q3
176
58.70M
79.97%
-14.73M
2023Q2
180
58.28M
81.90%
-25.39M
2023Q1
176
66.92M
93.93%
-18.56M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
M33 Growth LLC
13.75M
15.41%
-673.68K
-4.67%
Jun 05, 2025
OncologyCare Partners LLC
4.11M
4.61%
--
--
Mar 26, 2025
Deerfield Management Company, L.P.
3.36M
3.77%
--
--
Mar 31, 2025
TIFF Advisory Services, Inc.
2.98M
3.34%
--
--
Mar 31, 2025
Balyasny Asset Management LP
2.15M
2.41%
+421.77K
+24.44%
Mar 31, 2025
Josh Arnold Investment Consultant, LLC
1.99M
2.23%
+1.99M
--
Mar 31, 2025
The Vanguard Group, Inc.
1.75M
1.96%
-3.67K
-0.21%
Mar 31, 2025
Cincinnati Financial Corporation
1.24M
1.39%
-793.25K
-39.00%
Mar 31, 2025
Virnich (Daniel)
1.18M
1.33%
-20.39K
-1.69%
May 21, 2025
Hively (Bradford Daniel)
603.50K
0.68%
-108.53K
-15.24%
Jun 03, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
占比0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
ProShares UltraPro Russell2000
占比0%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 ETF
占比0%
Global X Russell 2000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
